...
机译:推定肿瘤抑制器SFRP3的表观遗断丧失与肺腺癌患者的预后不良相关
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Res Ctr Julich Inst Complex Syst Julich Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Rhein Westfal TH Aachen Inst Pathol Med Fac Aachen Germany;
Lung cancer; NSCLC; WNT signaling; SFRP3; DNA methylation;
机译:推定肿瘤抑制器SFRP3的表观遗断丧失与肺腺癌患者的预后不良相关
机译:肿瘤抑制因子ARID1A蛋白表达的丧失与原发性乳腺癌患者的预后不良相关
机译:肺癌1(TSLC1)表达中抑癌基因的下调与结肠癌患者预后不良有关。
机译:肺腺癌肿瘤浸润淋巴细胞的紧凑性测量与整体患者存活和免疫分数有关
机译:配对框基因5作为功能性肿瘤抑制因子的表观遗传学鉴定与胃癌患者预后不良相关。
机译:假定的抑癌基因SFRP3的表观遗传丧失与肺腺癌患者预后不良有关
机译:推定的肿瘤抑制因子sFRp3的表观遗传丧失与肺腺癌患者的预后不良相关